CD182 Antibody: Analyzing the Multiple Functions of CXCR2 Receptor in the Tumor Microenvironment and Immune Regulation

1. Concept of CXCR2 Receptor and CD182 Antibody

CXCR2 (CD182), a key chemokine receptor, regulates physiological and pathological processes by binding specific ligands and activating downstream signaling networks, controlling cell migration, proliferation, and differentiation. Its expression is tightly regulated via transcriptional, post-translational, and protein stability mechanisms, with cell type-specific expression patterns determining functional specificity. CD182 antibody is a highly specific tool that recognizes CXCR2, enabling detection, functional analysis, and targeted research of this receptor. It is available in monoclonal (high specificity, uniformity) and recombinant variants, with quality parameters (specificity, affinity, stability) directly impacting experimental reliability.

2. Research Frontiers

Research on CXCR2 focuses on its multifunctional roles in the tumor microenvironment (TME), immune regulation, infectious diseases, and beyond. Key frontiers include dissecting its context-dependent role in tumor progression (promoting angiogenesis/metastasis vs. anti-tumor activity), novel mechanisms in immune cell regulation (e.g., neutrophil circadian rhythms), and pathological functions in viral infections (e.g., SARS-CoV-2-induced pulmonary inflammation). CD182 antibodies facilitate exploration of CXCR2 crosstalk with other signaling pathways and development of targeted therapies (antagonists, ligand-neutralizing antibodies) combined with immune checkpoint inhibitors. Emerging directions include studying CXCR2 in metabolic regulation and circadian rhythms, expanding its translational scope.

3. Research Significance

CD182 antibody is indispensable for unraveling CXCR2’s complex functions and advancing translational research. In oncology, it aids in understanding TME immunosuppression (recruitment of neutrophils, MDSCs) and developing combination immunotherapies. In immunology, it enables study of CXCR2’s role in immune cell dynamics and autoimmune diseases. For infectious diseases, it supports investigation of inflammatory mechanisms and development of intervention strategies. CXCR2-targeted therapies hold promise for cancer, inflammatory disorders, and viral infections—CD182 antibodies provide critical tools for validating targets, evaluating drug efficacy, and identifying biomarkers for patient stratification.

4. Related Mechanisms, Research Methods, and Product Applications

4.1 CXCR2’s Regulatory Role in the Tumor Microenvironment

CXCR2 shapes the TME through immune cell coordination:

• Recruits neutrophils, macrophages, and myeloid-derived suppressor cells (MDSCs) to establish an immunosuppressive microenvironment.
• Exhibits context-dependent functions: promotes tumor angiogenesis and metastasis in most cases, while exerting anti-tumor activity under specific conditions.
• CD182 antibody applications: identify CXCR2+ cells in the TME via flow cytometry/IHC, study tumor-associated neutrophil recruitment/polarization, and evaluate CXCR2-targeted therapy effects on TME remodeling.

4.2 CXCR2 in Immune Cell Function Regulation

Recent discoveries reveal novel immune regulatory mechanisms:

• Neutrophil regulation: modulates circadian rhythmic fluctuations, maturation, ROS production, and NETosis.
• Neuroimmune interactions: activates inflammatory responses in autoimmune models (e.g., EAE) and inhibits central nervous system myelin regeneration.
• Endocrine-immune crosstalk: indirectly regulates reproductive/metabolic organ immune functions via the hypothalamic-pituitary-gonadal axis.
• CD182 antibody applications: analyze CXCR2 expression in immune subsets, track immune cell migration in inflammation models, and dissect signaling pathways mediating immune cell activation.

4.3 CXCR2 in Infectious Diseases

CXCR2 plays complex roles in infections:

• Exacerbates SARS-CoV-2-induced pulmonary inflammation and tissue damage by recruiting neutrophils to lesion sites.
• Pathogen- and tissue-specific functions require precise evaluation to avoid off-target effects in therapies.
• CD182 antibody applications: quantify CXCR2 expression in infected tissues, study immune cell infiltration mechanisms, and validate CXCR2 as a therapeutic target for infectious diseases.

4.4 CXCR2-Targeted Therapeutic Strategies: Challenges and Opportunities

• Challenges: Broad physiological involvement increases adverse effect risks; functional heterogeneity demands patient stratification.
• Opportunities: Combination of CXCR2 antagonists with immune checkpoint inhibitors for synergistic anti-tumor effects; ligand-specific neutralizing antibodies for precise intervention; tissue-specific regulation based on signaling network insights.
• CD182 antibody applications: evaluate drug-target engagement, monitor CXCR2 expression during therapy, and identify responsive patient populations.

4.5 Product Applications in Advanced Research

ANT BIO PTE. LTD.’s CD182 antibodies support diverse scenarios:

• Tumor Biology: Explore CXCR2+ immune cell recruitment and TME immunosuppression; evaluate combination therapy efficacy.
• Inflammation Research: Study granulocyte migration in models of pneumonia, peritonitis, and arthritis.
• Immunology: Dissect CXCR2’s role in neutrophil function and autoimmune disease pathogenesis.
• Infectious Diseases: Investigate viral-induced inflammatory mechanisms and test CXCR2-targeted interventions.

5. Brand Mission

ANT BIO PTE. LTD. is dedicated to empowering global oncology, immunology, and infectious disease research through innovative, high-quality reagents. We strive to develop cutting-edge antibodies, proteins, kits, and tools that enable researchers to unravel CXCR2’s multifunctional roles and advance targeted therapeutics. Our mission is to accelerate scientific discovery, facilitate the development of novel treatments for cancer, inflammation, and viral infections, and improve human health by providing reliable, reproducible, and high-performance research solutions. With a commitment to excellence, innovation, and customer-centricity, we aim to be a trusted partner for researchers advancing the frontiers of precision medicine.

6. Related Product List

Core Advantages of ANT BIO PTE. LTD.’s CD182 Antibodies

• High Specificity and Functional Binding: Specifically recognizes mouse/human CXCR2 (CD182), with high affinity for myeloid cells (neutrophils, monocytes); some clones block ligand binding for functional studies.
• Exceptional Stability and Consistency: Strict quality control ensures minimal batch-to-batch variation and reliable performance across flow cytometry, IHC, and functional assays.

7. AI Disclaimer

This article is AI-compiled and interpreted based on the original work. All intellectual property (e.g., images, data) of the original publication shall belong to the journal and the research team. For any infringement, please contact us promptly and we will take immediate action.

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.